| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.640.699 | 5.318.292 | 5.930.551 | 5.774.153 | 6.719.731 | 8.094.627 | 10.101.120 | 11.651.416 | 10.464.774 | 11.186.849 |
| Total Income - EUR | 4.776.397 | 5.404.172 | 6.030.248 | 5.895.464 | 6.800.191 | 8.253.558 | 10.253.594 | 11.558.112 | 10.641.369 | 11.302.420 |
| Total Expenses - EUR | 3.676.398 | 4.631.913 | 5.580.127 | 5.537.233 | 6.372.662 | 7.831.928 | 9.771.240 | 11.053.369 | 10.068.277 | 10.706.838 |
| Gross Profit/Loss - EUR | 1.100.000 | 772.260 | 450.120 | 358.230 | 427.529 | 421.630 | 482.354 | 504.743 | 573.092 | 595.582 |
| Net Profit/Loss - EUR | 1.086.241 | 646.601 | 375.457 | 298.326 | 350.935 | 353.321 | 410.767 | 429.631 | 487.546 | 502.761 |
| Employees | 75 | 90 | 109 | 114 | 113 | 128 | 157 | 117 | 125 | 131 |
Check the financial reports for the company - Jabs Glodeni S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.889.590 | 3.513.537 | 3.186.271 | 2.886.209 | 2.715.677 | 2.595.028 | 2.484.000 | 2.551.386 | 2.686.702 | 3.896.062 |
| Current Assets | 1.920.941 | 2.930.801 | 1.444.687 | 1.945.731 | 2.659.715 | 3.036.362 | 3.521.190 | 3.786.540 | 4.680.612 | 3.821.086 |
| Inventories | 669.277 | 687.899 | 675.191 | 793.030 | 672.028 | 972.589 | 1.225.238 | 1.327.520 | 1.259.403 | 1.132.581 |
| Receivables | 1.188.410 | 2.171.092 | 510.186 | 1.034.305 | 1.589.615 | 581.658 | 922.063 | 1.127.499 | 735.890 | 1.045.091 |
| Cash | 63.254 | 71.810 | 259.310 | 118.396 | 398.071 | 1.482.115 | 1.373.889 | 1.331.521 | 2.685.319 | 1.643.414 |
| Shareholders Funds | 5.730.552 | 6.318.709 | 4.460.168 | 4.676.643 | 4.937.010 | 5.196.736 | 5.505.266 | 5.951.977 | 6.421.474 | 6.888.348 |
| Social Capital | 134.274 | 132.905 | 130.656 | 128.258 | 125.774 | 123.390 | 120.654 | 121.028 | 120.661 | 119.987 |
| Debts | 85.477 | 127.300 | 170.963 | 158.860 | 435.584 | 437.559 | 513.567 | 395.392 | 921.134 | 817.162 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1625 - 1625" | |||||||||
| CAEN Financial Year |
1623
|
|||||||||
Comments - Jabs Glodeni S.r.l.